Study: Patient openness to research can depend on race and sex of study personnel

May 17, 2013

CINCINNATI--Researchers at the University of Cincinnati (UC) have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.

The study, presented today at the Society for Academic Emergency Medicine's annual meeting in Atlanta, that there is an interaction of the race and sex of the study assistant and the race of the patient.

Lead author Kimberly Hart says that her team found that black patients, both male and female, were about 15 percent less likely to be willing to participate in research when approached by a white male study assistant, compared to white patients.

However, black patients were about 15 percent more likely to be willing when approached by a white female study assistant. Conversely, black patients were about 50 percent less likely to be willing to participate in research when approached by a black female study assistant, compared to white patients.

The study builds on previous UC research reporting that black and female patients are less likely to agree to participate in research, despite being offered more frequent opportunities to participate.

"Social theories about relationships between medical providers or researchers and patients suggest that patients may have more trust in providers who are similar to them in terms of gender and race, but there are few research studies that directly address race and sex differences between medical researchers and patient participants," says Hart, a research associate in the department of emergency medicine. "Our team hypothesized that when a patient was approached by a study assistant of the same race or sex, the patient would be more willing to participate than when race and sex were different."

To test this, the team studied nearly 160,000 patients screened for clinical research by 89 different study assistants at the UC Medical Center emergency department and Jewish Hospital emergency department from January 2007 to December 2011.

The patient population was 60 percent white and 44 percent male, while the study assistants were 75 percent white and 44 percent male. Most patients, 89 percent, were willing to be approached for research.

"We found that willingness to participate in research is influenced by the race and sex of the study assistant, but the impact is different for different groups," says Hart. "As researchers, we should be aware of the impact of race and sex on our relationships with study participants. The relationship is much more complicated than we thought it would be, and we hope to conduct further research to better understand the reasons behind our observations. It is important to ensure equal representation of all persons in clinical research and only by understanding the factors that influence willingness to participate can we begin to prevent bias."
-end-
Co-authors of, "The Impact Of Race And Sex Of Study Personnel On The Decision To Participate In Research," include Andrew Ruffner, MPH, Carla McTaggert and Christopher Lindsell, PhD.

University of Cincinnati Academic Health Center

Related Clinical Research Articles from Brightsurf:

Day after COVID-19: Time to rethink oncology clinical research
This Viewpoint discusses how the COVID-19 pandemic may reshape clinical practice and clinical research as new technologies are incorporated and old practices are revisited and revamped.

Pregnant and lactating women with COVID-19: Scant clinical research
Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions.

Serum irisin: Pathogenesis and clinical research in cardiovascular diseases
In a new publication from Cardiovascular Innovations and Applications; Lutfu Askin, Kader Eliz Uzel, Okan Tanriverdi and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider serum irisin pathogenesis and clinical research in cardiovascular diseases.

People fearful of taking part in vital clinical research
A review, led by researchers at the University of York and Hull York Medical School, has found that fear about testing new treatments and possible side effects was the most common reason given by patients for not wanting to participate.

Clinical research improves health of UK economy and NHS
The value of clinical research to the NHS, the UK economy and jobs market has been evaluated in a new report, which provides an assessment of the economic impact of the National Institute for Health Research Clinical Research Network's (NIHR CRN) activities to support clinical research in England.

Research discovery leads to new clinical trial for myelofibrosis patients
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

New research: Financial disclosure lacking in publication of clinical trials
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows.

How to ethically conduct clinical research during public health emergencies
Carnegie Mellon University's Alex John London, a prominent bioethicist, has co-authored a viewpoint article in PLOS: Neglected Tropical Diseases on the ethics of clinical research during public health emergencies, like Ebola outbreaks.

Early results from clinical trials not all they're cracked up to be, shows new research
When people are suffering from a chronic medical condition, they may place their hope on treatments in clinical trials that show early positive results.

Collection provides tools to improve clinical research in Africa and Asia
Quality assurance of clinical research is critical to ensure meaningful results in compliance with universal ethical standards.

Read More: Clinical Research News and Clinical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.